Is Catalyst Pharmaceuticals (CPRX) Still Undervalued After its Recent Multi-Year Share Price Surge? [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
See our latest analysis for Catalyst Pharmaceuticals. That steady run has not been a fluke, with a 90 day share price return of 18.28 percent and a five year total shareholder return of 559.78 percent, suggesting momentum is still firmly on Catalyst Pharmaceuticals side at the current 23.62 dollars share price. If steady, compounding gains in a niche player appeal to you, it could be worth exploring other specialised opportunities across healthcare via healthcare stocks With rare disease revenues climbing, margins healthy, and the share price still sitting at a sizable discount to analyst targets and intrinsic value estimates, is Catalyst Pharmaceuticals a genuine buying opportunity, or is the market already pricing in future growth? With the narrative fair value sitting well above Catalyst Pharmaceuticals last close of 23.62 dollars, the story leans toward meaningful upside rather than complacency. Earlier detection and improved diagnostic accuracy of neuromuscular and rar
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b-)" rating.MarketBeat
- Analysts See Big Upside in Catalyst Pharmaceuticals, Inc. (CPRX) [Yahoo! Finance]Yahoo! Finance
- Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]Yahoo! Finance
- Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]Seeking Alpha
CPRX
Earnings
- 11/5/25 - Beat
CPRX
Sec Filings
- 12/12/25 - Form 144
- 12/10/25 - Form 4
- 12/10/25 - Form 4
- CPRX's page on the SEC website